“… 2 Despite adequate screening success and recently published studies describing equal procedural effects in atrial and ventricular functional TR, Cardioband remains a selective therapy concept. 3 Unlike newer concepts, it does not carry the potential of an “all-comer device.” 4 CCTA provides critical insights in screening for transcatheter annuloplasty, which is also required before orthotopic and heterotopic transcatheter tricuspid valve replacement.…”